MANISH LUHANA: Open Payments
NPI 1558347641 · PARSIPPANY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 62 payments from 18 companies in 2025. Trend: 2023 $972 · 2024 $1,038 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $273 |
| Lilly USA, LLC | 12 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| Exact Sciences Corporation | 3 | $67 |
| Amgen Inc. | 4 | $66 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $26 |
Products named: FARXIGA, Kerendia, MOUNJARO, Cologuard Collection Kit, JARDIANCE, ZORYVE, REPATHA, BREZTRI.
Industry payments across NJ — which companies pay providers there.
